Musculoskeletal/Orthopedics

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at…

Cognitive behaviorial therapy

A study of 701 adults with subacute or chronic back pain found that cognitive behavioral therapy reduced pain and disability compared to those who…

Osteoporosis-not just for women

Most elderly men don’t know they are at risk for osteoporosis-and they probably won’t find out until a nurse tells them.

Drugs Today – November 2008

Web Exclusive! An update of drug news, including alerts, approvals, and removals at www.AmericanNurseToday.com/journal.

Paget’s disease: A therapy update

Pain, arthritis, fractures, and skeletal deformities are calling cards of Paget’s disease. A new one-dose drug therapy can produce extended remission.

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who…

Cognitive behaviorial therapy

A study of 701 adults with subacute or chronic back pain found that cognitive behavioral therapy reduced pain and disability compared to…

Osteoporosis-not just for women

Most elderly men don’t know they are at risk for osteoporosis-and they probably won’t find out until a nurse tells them.

Drugs Today – November 2008

Web Exclusive! An update of drug news, including alerts, approvals, and removals at www.AmericanNurseToday.com/journal.

Paget’s disease: A therapy update

Pain, arthritis, fractures, and skeletal deformities are calling cards of Paget’s disease. A new one-dose drug therapy can produce extended remission.

Test Your Knowledge

Which of the following best describes Wegovy’s FDA-approved use?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.